Technology area: Biotechnology & Pharmaceuticals
25 pending office actions • 22 art units • 25 examiners • 0 of 25 (0%) have an AI response strategy ready • 36 patents granted in the last 365 days
The University of British Columbia has 24 pending office actions in Biotechnology & Pharmaceuticals. Each matter is assigned to a distinct examiner, while the docket spans 21 distinct art units, indicating complete examiner dispersion with some art-unit overlap.
VARGAS MONTALVO, DIXOMARA is the busiest examiner, with 1 pending matter. Counsel should rely on coordinated matter review and shared biotechnology claim guidance rather than examiner concentration.
Based on the USPTO statutory response window for each pending office action. 9 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 9 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 4 (16%) |
| §103 only | 4 (16%) |
| §102 only | 2 (8%) |
| Double-patenting only | 1 (4%) |
| Double-patenting + other | 2 (8%) |
| Multi-statute (no §101) | 11 (44%) |
| No statute on record | 1 (4%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VARGAS MONTALVO, DIXOMARA | 1 | 92.6% | +8.4% |
| COLLARD JR, DWANE EDWARD | 1 | 0.0% | +0.0% |
| YOUNG, MICAH PAUL | 1 | 55.2% | +30.0% |
| HEINCER, LIAM J | 1 | 55.8% | +26.0% |
| SHTERENGARTS, SAMANTHA L | 1 | 79.5% | +8.0% |
| HOQUE, MOHAMMAD M | 1 | 85.3% | +9.3% |
| MCLEOD, AFRICA MHAIRIE | 1 | 52.8% | +67.7% |
| GREENE, IVAN A | 1 | 18.8% | +6.1% |
| JOHNSON, CHRISTOPHER LINDSAY | 1 | 48.6% | +78.3% |
| DAUNER, JOSEPH G | 1 | 57.0% | +35.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18564588 | MRNA DELIVERY USING LIPID NANOPARTICLES | GREENE, IVAN A | 46d overdue |
| 18317071 | PROBIOTIC COMPOSITIONS AND USES THEREOF | DEVI, SARVAMANGALA | 38d overdue |
| 17919455 | ELECTROLYTIC CONVERSION OF CARBON-CONTAINING IONS USING POROUS METAL ELECTRODES | PARENT, ALEXANDER RENE | 35d overdue |
| 17919459 | COMPOSITIONS AND METHODS FOR INHIBITING TDP-43 AND FUS AGGREGATION | POLIAKOVA-GEORGAN, EKATERINA | 15d overdue |
| 18458088 | APPARATUS AND METHODS FOR COMBINATORIAL MATERIAL SCREENING AND DISCOVERY | MILLER, JR, JOSEPH ALBERT | 9d overdue |
| 17561408 | MOLECULAR SUBTYPING, PROGNOSIS, AND TREATMENT OF BLADDER CANCER | VANN-OJUEKAIYE, KENDRA RAYCHELL | 4d overdue |
| 18037287 | PROTEIN HYDROGELS AND METHODS FOR THEIR PREPARATION | NIEBAUER, RONALD T | 15d |
| 19408302 | METHODS AND APPARATUS FOR NEAR INFRARED SPECTROSCOPY | VARGAS MONTALVO, DIXOMARA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19030494 | LIMIT SIZE LIPID NANOPARTICLES AND RELATED METHODS | YOUNG, MICAH PAUL | — |
| 18947297 | AEROGELS ASSEMBLED FROM MICROFIBERS, METHODS FOR THEIR PREPARATION AND USES THEREOF | HEINCER, LIAM J | — |
| 18712070 | METHODS AND COMPOSITIONS FOR MODULATING FIBRINOGEN | MCLEOD, AFRICA MHAIRIE | — |
| 18565049 | Polymeric Antifouling Coating with Antimicrobial Peptides | JOHNSON, CHRISTOPHER LINDSAY | — |
| 18563344 | DIAGNOSTIC FOR SEPSIS ENDOTYPES AND/OR SEVERITY | DAUNER, JOSEPH G | — |
| Art Unit | Apps |
|---|---|
| 1618 | 2 |
| 1619 | 2 |
| 1682 | 2 |
| 3798 | 1 |
| 3792 | 1 |
| 1767 | 1 |
| 1623 | 1 |
| 2817 | 1 |
| 1635 | 1 |
| 1691 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19408302 | METHODS AND APPARATUS FOR NEAR INFRARED SPECTROSCOPY | VARGAS MONTALVO, DIXOMARA | 3798 | §102§103§112 | Non-Final OA | — | Pending | Dec 03, 2025 |
| 19098463 | APPARATUS AND METHODS FOR MAINTAINING PHYSIOLOGICAL FUNCTIONS | COLLARD JR, DWANE EDWARD | 3792 | §101§103§112Other | Non-Final OA | — | Pending | Apr 02, 2025 |
| 19030494 | LIMIT SIZE LIPID NANOPARTICLES AND RELATED METHODS | YOUNG, MICAH PAUL | 1618 | DP | Non-Final OA | — | Pending | Jan 17, 2025 |
| 18947297 | AEROGELS ASSEMBLED FROM MICROFIBERS, METHODS FOR THEIR PREPARATION AND USES THEREOF | HEINCER, LIAM J | 1767 | §103 | Final Rejection | — | Pending | Nov 14, 2024 |
| 18846525 | ALOTAKETAL COMPOUNDS AND DERIVATIVES THEREOF FOR USE AS ANTIVIRAL AGENTS | SHTERENGARTS, SAMANTHA L | 1623 | §102 | Non-Final OA | — | Pending | Sep 12, 2024 |
| 18839351 | METHODS OF FABRICATING MICRO ELECTRO-MECHANICAL SYSTEMS STRUCTURES | HOQUE, MOHAMMAD M | 2817 | §102§103 | Non-Final OA | — | Pending | Aug 16, 2024 |
| 18712070 | METHODS AND COMPOSITIONS FOR MODULATING FIBRINOGEN | MCLEOD, AFRICA MHAIRIE | 1635 | §103§112 | Non-Final OA | — | Pending | May 21, 2024 |
| 18564588 | MRNA DELIVERY USING LIPID NANOPARTICLES | GREENE, IVAN A | 1619 | §103 | Non-Final OA | 46d overdue | Pending | Nov 30, 2023 |
| 18565049 | Polymeric Antifouling Coating with Antimicrobial Peptides | JOHNSON, CHRISTOPHER LINDSAY | 1691 | §102§103 | Non-Final OA | — | Pending | Nov 28, 2023 |
| 18563344 | DIAGNOSTIC FOR SEPSIS ENDOTYPES AND/OR SEVERITY | DAUNER, JOSEPH G | 1682 | §101§102§103§112 | Non-Final OA | — | Pending | Nov 21, 2023 |
| 18285019 | USE OF PSYCHEDELICS TO TREAT DEMENTIA | BORALSKY, LUKE ALAN | 1624 | §103§112DP | Non-Final OA | — | Pending | Sep 29, 2023 |
| 18458088 | APPARATUS AND METHODS FOR COMBINATORIAL MATERIAL SCREENING AND DISCOVERY | MILLER, JR, JOSEPH ALBERT | 1712 | §102§103 | Final Rejection | 9d overdue | Pending | Aug 29, 2023 |
| 18219458 | RADIOMETAL-BINDING COMPOUNDS FOR DIAGNOSIS OR TREATMENT OF PROSTATE SPECIFIC MEMBRANE ANTIGEN-EXPRESSING CANCER | BAEK, JONGHWAN NMN | 1618 | §103 | Final Rejection | — | Pending | Jul 07, 2023 |
| 18266787 | CYTOCHROME P450 MONOOXYGENASES AND USES THEREOF | HUTSON, RICHARD G | 1652 | §101§102 | Final Rejection | — | Pending | Jun 12, 2023 |
| 18253518 | ANTINOCICEPTIVE COMPOUNDS AND USES THEREOF | BRADLEY, CHRISTINA | 1654 | §102§103§112 | Non-Final OA | — | Pending | May 18, 2023 |
| 18037287 | PROTEIN HYDROGELS AND METHODS FOR THEIR PREPARATION | NIEBAUER, RONALD T | 1658 | §102§103§112Other | Final Rejection | 15d | Pending | May 16, 2023 |
| 18317071 | PROBIOTIC COMPOSITIONS AND USES THEREOF | DEVI, SARVAMANGALA | 1645 | §102§103§112 | Non-Final OA | 38d overdue | Pending | May 13, 2023 |
| 18035578 | A Method of Treating Depression by Immune Modulation | PIHONAK, SARAH | 1627 | §102§103§112DP | Non-Final OA | — | Pending | May 05, 2023 |
| 18015159 | SILVER ENHANCED CANNABINOID ANTIBIOTICS | ALAWADI, SARAH | 1619 | §103§112 | Non-Final OA | — | Pending | Jan 09, 2023 |
| 17919455 | ELECTROLYTIC CONVERSION OF CARBON-CONTAINING IONS USING POROUS METAL ELECTRODES | PARENT, ALEXANDER RENE | 1795 | §103§112 | Final Rejection | 35d overdue | Pending | Nov 01, 2022 |
| 17919459 | COMPOSITIONS AND METHODS FOR INHIBITING TDP-43 AND FUS AGGREGATION | POLIAKOVA-GEORGAN, EKATERINA | 1637 | §102§103§112 | Non-Final OA | 15d overdue | Pending | Oct 17, 2022 |
| 17843561 | MICROMOTOR-INTEGRATED ENDOSCOPIC SIDE-VIEWING PROBE | STANFORD, CHRISTOPHER J | 2872 | §103 | Final Rejection | 147d overdue | Pending | Jun 17, 2022 |
| 17561408 | MOLECULAR SUBTYPING, PROGNOSIS, AND TREATMENT OF BLADDER CANCER | VANN-OJUEKAIYE, KENDRA RAYCHELL | 1682 | §101§103DP | Non-Final OA | 4d overdue | Pending | Dec 23, 2021 |
| 17321645 | HIGHLY PARALLEL ASSAYS FOR SIMULTANEOUS IDENTIFICATION OF ANTIBODY SEQUENCES AND BINDING PARTNERS | WILSON, MICHAEL C | 1638 | Other | Final Rejection | 2d overdue | Pending | May 17, 2021 |
| 17282319 | Transcription Factor BRN2 Inhibitory Compounds as Therapeutics and Methods for Their Use | VAJDA, KRISTIN ANN | 1622 | §102 | Final Rejection | — | Pending | Apr 01, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialThe University of British Columbia has 25 pending office actions as of October 2026, spread across 22 art units and 25 examiners.
Dixomara Vargas Montalvo has the most, with 1 of The University of British Columbia's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
